What has been reported to FDA about pain stimulators?

The Food and Drug Administration receives tens of thousands of reports each year about implanted spinal cord and dorsal root ganglion stimulators, devices used for chronic pain conditions that include complex regional pain syndrome (CRPS). The tables here count those reports and list recent recalls. FDA states that the reports are unverified and cannot be used to calculate rates.

A painted brass microscope with a poppy and lupine.

How many reports has FDA received about pain stimulators?

The first table counts the reports FDA received each year since 2010 for three kinds of implanted pain stimulator, and the row for the current year is marked "to date." The second table sorts the reports from the last full year by the type of event the reporter selected. Both tables are counted from FDA's public data on the retrieval date printed beneath them.

Adverse event reports FDA received for spinal cord and dorsal root ganglion stimulators, by year
Year receivedReports
20109,419
201111,603
201219,004
201326,861
201422,099
201519,196
201620,484
201725,264
201831,006
201933,230
202030,895
202126,969
202225,436
202335,587
202437,470
202533,747
2026 (to date)28,410
What the 2025 reports described
Report typeReports
Injury27,179
Malfunction6,537
Death28
Other3

Source: openFDA device adverse event (MAUDE) and recall data, U.S. Food and Drug Administration. Retrieved . Report counts, not rates. FDA: adverse event reports are unverified, may be duplicated, and do not establish that a device caused the event. FDA does not publish how many devices were implanted. Most stimulators are implanted for conditions other than CRPS.

What is a medical device report?

A medical device report is a notice to FDA that a device may have been involved in a death, a serious injury or a malfunction. FDA's reporting regulation, 21 CFR Part 803, requires a manufacturer to report when it learns that one of its devices "may have caused or contributed to a death or serious injury." Hospitals and other user facilities must report device-related deaths and serious injuries.

Clinicians, patients and caregivers can file voluntary reports. FDA stores the reports in a database called MAUDE, the Manufacturer and User Facility Device Experience database, and republishes them through its openFDA service, which is updated weekly.

Which pain stimulators do the FDA counts cover?

The counts cover the three FDA product codes for implanted stimulators of the spinal cord and the dorsal root ganglion. A product code is FDA's label for a type of device. Peripheral nerve stimulators and implanted drug pumps have their own codes and are not counted here.

FDA product codes counted in the pain stimulator report tables
Product codeFDA's name for the device typeFDA device class
LGWStimulator, spinal-cord, totally implanted for pain reliefClass 3
GZBStimulator, spinal-cord, implanted (pain relief)Class 2
PMPDorsal root ganglion stimulator for pain reliefClass 3

What does a stimulator report count mean, and what does it not mean?

A count is the number of reports FDA received, and nothing more. FDA's description of the database states: "MDR data is not intended to be used either to evaluate rates of adverse events, evaluate a change in event rates over time, or to compare adverse event occurrence rates across devices."

A report is also not a finding of fault. FDA states that "the submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event." The openFDA service adds that the reports "do not undergo extensive validation or verification." One event can produce more than one report, and many events are never reported.

Why can FDA stimulator reports not be turned into a rate?

A rate needs two numbers, and the reports supply one. FDA states that the incidence of an event "cannot be determined from this reporting system alone due to under-reporting of events, inaccuracies in reports, lack of verification that the device caused the reported event, and lack of information about frequency of device use." No public figure says how many stimulators are implanted.

Clinical studies do measure rates. A Cleveland Clinic review of 707 spinal cord stimulator cases found hardware complications in 38 percent and infection in 4.5 percent (Mekhail 2011). An insurance claims study of 7,560 patients found that 22.1 percent had a revision or removal within two years (Dhruva 2023).

What do the report types injury, malfunction and death mean?

The report type is the category the reporter chose for the event: death, serious injury or malfunction. A manufacturer files a malfunction report when a device malfunctioned and would be likely to cause or contribute to a death or serious injury if the malfunction happened again. FDA cautions that a report is classified as a death only when the reporter believes the device caused or may have contributed to the death. The word "death" in a report's text does not make it a death report.

What problems do the stimulator reports describe?

Reporters attach standard codes for the patient problem and the device problem. In the data retrieved on November 20, 2026, the patient problem coded most often across the three product codes was "Inadequate Pain Relief." Frequent device problem codes included charging problems, high impedance, battery problems and migration, which means a lead or generator moved from where the surgeon placed it.

The fifteen most frequent codes of each kind are in the file at /data/stimulator-reports.json. A code records what the reporter selected and is not a verified diagnosis.

How many of the stimulator reports involve people with CRPS?

The counts cannot answer that, because a product code covers every patient who has the device, whatever the diagnosis. Spinal cord stimulators are implanted for several chronic pain conditions besides complex regional pain syndrome. A text search run on November 20, 2026 found the phrase "complex regional pain syndrome" in the narratives of 1,599 reports under code LGW, 17 under GZB and 10 under PMP. A narrative need not state the diagnosis, so those figures are a floor and not a share.

Which pain stimulators have been recalled?

The list shows the ten most recent recalls FDA has recorded under the three product codes, with the company, the product and the reason. FDA uses the word recall for a correction as well as a removal. A correction fixes a problem where the device is used, such as a software update to a programmer.

  1. Boston Scientific Neuromodulation Corporation, recall started September 30, 2026 (Open, Classified)Product: Nalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the Nalu Neurostimulation SystemReason FDA lists: Therapy Disc (TD) that powers and sends stimulation signals to an Implantable Pulse Generator (IPG), part of a neurostimulation system, has a firmware issue that causes the TD to attempt to restart, then fail, leading it to become non-functional, and if a secondary TD is unavailable, this may lead IPG to become non-functional, thus unable to inhibit transmission of pain signals.
  2. Boston Scientific Neuromodulation Corporation, recall started June 17, 2026 (Open, Classified)Product: INFINION CX LEAD KIT, 50CM, Model: SC-2317-50, Material: M365SC2317500; INFINION CX LEAD KIT, 70CM, Model: SC-2317-70, Material: M365SC2317700. part of the Boston Scientific Spinal Cord Stimulator (SCS) Systems.Reason FDA lists: Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.
  3. Boston Scientific Neuromodulation Corporation, recall started April 29, 2026 (Open, Classified)Product: Boston Scientific Model SC-4318, Clik X Anchor REF: M365SC43180Reason FDA lists: Sterile anchors my lack sterility assurance.
  4. Medtronic Neuromodulation, recall started December 3, 2025 (Open, Classified)Product: A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).Reason FDA lists: Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
  5. Medtronic Neuromodulation, recall started November 20, 2025 (Open, Classified)Product: Restore Clinician Programmer Application (CP App), Model A71100 used with the following programmers: CT900A PROG CT900A CLINICIAN TABLET US CT900B PROG CT900B CLINICIAN TABLET EU -UK CT900C PROG CT900C CLINICIAN TABLET Reason FDA lists: Software issue where a Device Reset message displayed on the app was unable to be cleared. In rare cases, this resulted in an inability to resume therapy, and the patient experienced a recurrence of underlying pain symptoms. Resolution would require surgical replacement of the INS.
  6. Abbott Medical, recall started October 6, 2025 (Open, Classified)Product: Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400Reason FDA lists: There is a potential issue affecting Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generators (IPGs), Model 32400 and Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generators (IPGs), Model 62400 . These devicess may experience a loss of communication with the Clinician Programmer (CP) and/or the Patient Controller (PC).
  7. Medtronic Neuromodulation, recall started March 4, 2025 (Open, Classified)Product: Stimulation RC Clinician Programmer Application, Model A71400, when used with the Inceptiv (Model 977119) and Intellis Pro (Model 977118) neurostimulatorsReason FDA lists: There is a software issue that can permanently disable communication with an implantable neurostimulator (INS) when a specific intraoperative programming sequence is used.
  8. Medtronic Neuromodulation, recall started September 18, 2024 (Open, Classified)Product: Medtronic Recharger Kits, RS6230, RS7230, and RS5220A, containing components WR9230 and WR9220A Recharger for rechargeable implantable neurostimulators. The Rechargers are used with Neurostimulator Inceptiv INS Model 97Reason FDA lists: The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
  9. Medtronic Neuromodulation, recall started August 21, 2024 (Open, Classified)Product: Vanta Implantable Neurostimulator (INS), Model 977006Reason FDA lists: Model 977006 Vanta INS batterty life has depleted faster than HCPs or patients expected leading to outpatient reprogramming or earlier than anticipated surgical replacements.
  10. Boston Scientific Neuromodulation Corporation, recall started July 17, 2024 (Open, Classified)Product: WAVEWRITER ALPHA: Model: SC-1216, 16 IPG KIT, REF: M365SC12160; Model: SC-1232, 32 IPG KIT, REF: M365SC12320Reason FDA lists: Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset, which may lead to transient loss of stimulation; patients may experience undesired sensations when therapy turns off for approx. 10-15 seconds and then back on, which may lead patient to request surgical intervention for replacement or revision.

Source: openFDA device adverse event (MAUDE) and recall data, U.S. Food and Drug Administration. Retrieved . FDA lists 104 recalls under these product codes in all; the ten newest are shown.

FDA states that a recall "does not always mean that you must stop using the product," and that a recalled implant "does not always have to be explanted from patients." The status shown for each recall can be stale: openFDA notes that FDA "does not update the status of a recall after the recall has been classified."

How was the FDA stimulator query built?

A script on this site queries the openFDA device adverse event interface for reports whose product code is LGW, GZB or PMP. The script asks for totals by product code, by date received, by event type for the last full calendar year, and by patient and device problem code. A second query asks the openFDA recall interface for the 25 newest recalls under the same codes. The script runs weekly. FDA releases openFDA data into the public domain and asks for credit, which appears under each table.

How can a patient use the FDA reports before a stimulator implant?

A patient can use the reports to learn which problems are reported and to prepare questions for the implanting physician. The reports show kinds of problems: lost pain relief, leads that move, charging and battery faults, infection. The reports cannot show how likely any of them is. openFDA's own instruction is direct: "Do not rely on openFDA to make decisions regarding medical care. Always speak to your health provider about the risks and benefits of FDA-regulated products."

How can a lawyer use FDA stimulator reports in a device case?

A lawyer can use the reports and recalls to learn what a manufacturer told FDA about a device model and when. A recall entry names the company, the product and the reason. An individual report gives the event date, the model and a narrative, with personal details removed.

The reports carry a built-in limit. Under 21 CFR 803.16, a report "does not necessarily reflect a conclusion by the party submitting the report or by FDA that the report or information constitutes an admission that the device" caused or contributed to the event. CRPS from a defective product or device covers the California claim.

Common questions

Not by itself. FDA states that medical device report data is not intended to be used to evaluate a change in event rates over time. The openFDA service notes that common products may have more reports because more people use them, and that increases in total reports are likely caused by improved reporting. The number of stimulators implanted each year is not published, so a rising count cannot be compared with rising use.

FDA accepts voluntary reports from patients, caregivers and health care professionals through MedWatch, its safety information and adverse event reporting program. A report can describe a serious adverse event, a product quality problem or a therapeutic failure. The manufacturer has its own duty to report when it learns of a serious injury or a reportable malfunction. The implanting physician should also be told about any device problem.

Not necessarily. FDA states that a medical device recall does not always mean a person must stop using the product, and that a recalled implant does not always have to be explanted. A recall can mean the device needs to be checked, adjusted or fixed. FDA explains that when an implant could fail unexpectedly, companies often tell doctors to contact their patients to discuss the risk of removing the device compared with leaving it in place.

FDA's MAUDE database is public and searchable, and it holds the last ten years of reports. Each report shows the brand name, the model number, the event date and a narrative. FDA removes personal information before release and replaces it with the marking "(b)(6)," so a report cannot be searched by a patient's name. Each report carries its own report number.

The tables on this page combine the three product codes. FDA assigns dorsal root ganglion stimulators their own code, PMP, and assigns spinal cord stimulators the codes LGW and GZB. The downloadable data file on this site gives the all-time report total for each code separately. The yearly table and the event type table are not split by code.

openFDA states that its device adverse event data and its recall data are updated weekly. A script on this site pulls new totals once a week and prints the retrieval date under each table. The total for the current year grows with each retrieval until the year is complete.

Sources

Every source below was opened and read for this page. The date is when it was last checked.

  1. openFDA device adverse event and recall dataDataset · U.S. Food and Drug Administration · checked
  2. openFDA Device Adverse Event OverviewDataset · U.S. Food and Drug Administration · checked
  3. About Manufacturer and User Facility Device Experience (MAUDE) DatabaseGovernment agency · U.S. Food and Drug Administration · checked
  4. Medical Device Reporting (MDR): How to Report Medical Device ProblemsGovernment agency · U.S. Food and Drug Administration · checked
  5. openFDA Device Recall OverviewDataset · U.S. Food and Drug Administration · checked
  6. What is a Medical Device Recall?Government agency · U.S. Food and Drug Administration · checked
  7. openFDA Terms of ServiceGovernment agency · U.S. Food and Drug Administration · checked
  8. Product Classification: stimulator, spinal-cord, totally implanted for pain relief (product code LGW)Dataset · U.S. Food and Drug Administration · checked
  9. Retrospective review of 707 cases of spinal cord stimulation: indications and complicationsStudy · Pain Practice (Mekhail et al.), 2011 · checked
  10. Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic PainStudy · JAMA Neurology (Dhruva et al.), 2023 · checked

Ask a lawyer about your CRPS case

Free case review. No fee unless we recover. A person from Wise Law reads every message.

What happened before the CRPS started? (optional)
Has a doctor diagnosed CRPS? (optional)
Or call (424) 235-7879

Submitting this form does not create an attorney-client relationship. An attorney-client relationship is formed only by a signed written fee agreement.

Text usCall